Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis.

Sven Klaschik1, Ihsan Gursel, Dennis M Klinman

  • 1Section of Retroviral Research, Center for Biologics Evaluation and Research, Food and Drug Administration, Building 29A, Room 3D10, Bethesda, MD 20892, USA.

Molecular Immunology
|August 26, 2006
PubMed
Summary

CpG oligodeoxynucleotides (ODN) activate Toll-like receptor 9 (TLR9), initiating immune responses. Gene expression analysis reveals key regulators like TNF and NFKB1, and identifies genes that both promote and dampen this immune stimulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Features, Treatment Outcomes, and Cytokine Levels in Pediatric Tularemia Patients in Türkiye.

The American journal of tropical medicine and hygiene·2026
Same author

Circulating extracellular vesicles drive innate immune dysregulation in MIS-C.

The Journal of allergy and clinical immunology·2026
Same author

Frailty in anesthesia.

Current opinion in anaesthesiology·2026
Same author

Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis.

Journal of extracellular vesicles·2026
Same author

A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine.

Vaccine·2025
Same author

Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesicles.

Journal of controlled release : official journal of the Controlled Release Society·2024

Area of Science:

  • Immunology
  • Molecular Biology
  • Genomics

Background:

  • Unmethylated CpG motifs are recognized by Toll-like receptor 9 (TLR9).
  • TLR9 activation triggers innate immune responses, including cytokine and chemokine production.
  • CpG oligodeoxynucleotides (ODN) are synthetic molecules that mimic these motifs.

Purpose of the Study:

  • To investigate the temporal changes in gene expression following CpG ODN stimulation.
  • To identify key regulatory genes involved in the early immune response to TLR9 activation.
  • To uncover novel genes associated with CpG-induced immune stimulation and regulation.

Main Methods:

  • Murine spleen cells were stimulated with CpG ODN.
  • Microarray analysis of cDNA was performed at various time points (2h, 4h, 8h).

Related Experiment Videos

  • Network analysis was used to identify key regulatory genes.

    • Main Results:

    • Significant up-regulation of eight genes was observed 2 hours post-stimulation, primarily involved in immune responses.
    • TNF and NFKB1 were identified as key regulators at 2 hours, with IL1B also playing a role at 4 hours.
    • At 8 hours, TNF, IFNG, and MYC were dominant regulators, and genes down-regulating the response were identified.

    Conclusions:

    • CpG ODN stimulation via TLR9 induces a complex and dynamic gene expression profile.
    • Novel genes involved in initiating and terminating the immune response were identified.
    • This study provides insights into the regulatory mechanisms of TLR9-mediated immune stimulation.